Mark C. McKenna - 17 Jun 2025 Form 4 Insider Report for Apogee Therapeutics, Inc. (APGE)

Role
Director
Signature
/s/ Matthew Batters, as attorney-in-fact for Mark McKenna
Issuer symbol
APGE
Transactions as of
17 Jun 2025
Net transactions value
$0
Form type
4
Filing time
20 Jun 2025, 20:04:24 UTC
Previous filing
02 Jun 2025
Next filing
11 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
McKenna Mark C. Director C/O APOGEE THERAPEUTICS, INC., 221 CRESCENT ST., BLDG. 17, STE. 102B, WALTHAM /s/ Matthew Batters, as attorney-in-fact for Mark McKenna 20 Jun 2025 0001749623

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APGE Stock Option (Right to Buy) Award $0 +14,461 $0.000000 14,461 17 Jun 2025 Common Stock 14,461 $41.66 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents the right to purchase 14,461 shares of the Issuer's common stock and will vest on the one-year anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer on such vesting date.